OUR PRODUCTS

MOBILE APPS

GENERAL INFO

MDNAF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Medicenna Therapeutics (MDNAF) Earnings Date & Reports

Medicenna Therapeutics Corp is a Canada-based immuno-oncology company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MDNAF is expected to report earnings to rise 16.59% to -5 cents per share on November 14

Medicenna Therapeutics MDNAF Stock Earnings Reports

Q3'25

Est.

$-0.05

Q2'25

Est.

$-0.04

Q1'25

Beat

by $0.06

Q4'24

Est.

$-0.05

Q3'24

Beat

by $0.01

The last earnings report on July 31 showed earnings per share of -4 cents, meeting the estimate of -4 cents. With 41.48K shares outstanding, the current market capitalization sits at 65.47M.

View a ticker or compare two or three

Compare

MDNAF

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For MDNAF
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MDNAF showed earnings on July 31, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2 Bloor Street W.

Phone

+1 416 648-5555

Employees

Web

https://www.medicenna.com